Protagenic Therapeutics News

SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Armistice Capital, LLC(5.10%),Steven Boyd(5.10%)

Nov 15 06:22

10-Q: Q3 2024 Earnings Report

Nov 15 05:28

8-K: Current report

Nov 5 20:41

8-K: Current report

Oct 30 18:07

8-K: Current report

Sep 18 18:02

10-Q: Q2 2024 Earnings Report

Aug 15 05:01

8-K: Current report

Jul 27 05:34

S-3: Registration statement for specified transactions by certain issuers

Jun 15 05:35

8-K: Current report

May 25 04:41

8-K: Current report

May 22 21:19

10-Q: Q1 2024 Earnings Report

May 16 04:44

10-K/A: Annual report (Amendment)

May 14 18:09

10-K/A: Annual report (Amendment)

Apr 25 00:47

Protagenic Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director WRIGHT TIMOTHY R

Apr 2 09:43

Protagenic Therapeutics | 10-K: FY2023 Annual Report

Apr 2 04:03

Protagenic Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Stein Robert Benjamin

Mar 30 09:33

Protagenic Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Barrage Khalil

Mar 30 09:33

Protagenic Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Buell Jennifer

Mar 30 09:33

Protagenic Therapeutics | 4: Statement of changes in beneficial ownership of securities-Officer ARMEN GARO H

Mar 30 09:33

Protagenic Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Corvese Brian

Mar 30 09:33